2nd Motion For Cymbalta Withdrawal MDL To Be Heard Oct. 1

(August 18, 2015, 1:33 PM EDT) -- WASHINGTON, D.C. — Centralization of at least 43 federal Cymbalta withdrawal complaints will again be considered at the Oct. 1 meeting of the Judicial Panel on Multidistrict Litigation (JPMDL), the panel announced Aug. 14 (In Re: Cymbalta [Duloxetine] Products Liability Litigation, MDL Docket No. 2662, JPMDL).

On July 23, 52 plaintiffs filed a new motion for a Cymbalta withdrawal multidistrict litigation with the JPMDL. They say that since the panel rejected an MDL petition in December 2014, all plaintiffs are on the same discovery schedule and...
To view the full article, register now.